Asunto(s)
Anomalías Múltiples/genética , Proteínas Sanguíneas/deficiencia , Cromosomas Humanos X/ultraestructura , Anomalías Craneofaciales/genética , Eliminación de Gen , Hemofilia A/genética , Deformidades Congénitas de las Extremidades/genética , Proteínas de la Membrana/deficiencia , Anomalías Múltiples/embriología , Proteínas Sanguíneas/genética , Cromosomas Humanos X/genética , Anomalías Craneofaciales/embriología , Criptorquidismo/genética , Femenino , Genes Ligados a X , Hemofilia A/embriología , Humanos , Hipospadias/genética , Recién Nacido , Deformidades Congénitas de las Extremidades/embriología , Masculino , Proteínas de la Membrana/genética , Embarazo , Ultrasonografía Prenatal , Adulto JovenRESUMEN
The complex intrinsic and extrinsic pathways contributing to platelet activation profoundly impact hemostasis and thrombosis. Detailed cellular mechanisms that regulate calcium mobilization, Akt activation, and integrin signaling in platelets remain incompletely understood. Dematin is a broadly expressed actin binding and bundling cytoskeletal adaptor protein regulated by phosphorylation via cAMP-dependent protein kinase. Here, we report the development of a conditional mouse model specifically lacking dematin in platelets. Using the new mouse model termed PDKO, we provide direct evidence that dematin is a major regulator of calcium mobilization, and its genetic deletion inhibits the early phase of Akt activation in response to collagen and thrombin agonists in platelets. The aberrant platelet shape change, clot retraction, and in vivo thrombosis observed in PDKO mice will enable future characterization of dematin-mediated integrin activation mechanisms in thrombogenic as well as nonvascular pathologies.
Asunto(s)
Plaquetas , Trombosis , Animales , Ratones , Plaquetas/metabolismo , Calcio/metabolismo , Modelos Animales de Enfermedad , Fosforilación , Agregación Plaquetaria , Complejo GPIIb-IIIa de Glicoproteína Plaquetaria/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Trombosis/metabolismoRESUMEN
Dendritic cells (DCs) activated via TLR ligation experience metabolic reprogramming, in which the cells are heavily dependent on glucose and glycolysis for the synthesis of molecular building blocks essential for maturation, cytokine production, and the ability to stimulate T cells. Although the TLR-driven metabolic reprogramming events are well documented, fungal-mediated metabolic regulation via C-type lectin receptors such as Dectin-1 and Dectin-2 is not clearly understood. Here, we show that activation of DCs with fungal-associated ß-glucan ligands induces acute glycolytic reprogramming that supports the production of IL-1ß and its secretion subsequent to NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome activation. This acute glycolytic induction in response to ß-glucan ligands requires spleen tyrosine kinase signaling in a TLR-independent manner, suggesting now that different classes of innate immune receptors functionally induce conserved metabolic responses to support immune cell activation. These studies provide new insight into the complexities of metabolic regulation of DCs immune effector function regarding cellular activation associated with protection against fungal microbes.